热门资讯> 正文

Ligand Pharmaceuticals首席运营官Matthew Korenberg即将离职

2024-08-03 05:53

Ligand Pharmaceuticals (NASDAQ:LGND) announced that its President and Chief Operating Officer, Matthew Korenberg, will be departing from the company.
Filing

More on Ligand Pharmaceuticals

Ligand Pharmaceuticals: Solid Performer Performing Solidly
Amgen, Garmin among relative market leaders poised to outperform in coming months: BTIG
Ligand to buy APEIRON Biologics for $100M, ups 2024 revenue outlook

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。